DOCSLIB.ORG

Pdf/ Psittacosisqa Brachman PS, Editors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pdf/ Psittacosisqa Brachman PS, Editors A Peer-Reviewed Journal Tracking and Analyzing Disease Trends pages 361–518 EDITOR-IN-CHIEF D. Peter Drotman EDITORIAL STAFF EDITORIAL BOARD Dennis Alexander, Addlestone Surrey, United Kingdom Founding Editor Ban Allos, Nashville, Tennessee, USA Joseph E. McDade, Rome, Georgia, USA Michael Apicella, Iowa City, Iowa, USA Managing Senior Editor Barry J. Beaty, Ft. Collins, Colorado, USA Martin J. Blaser, New York, New York, USA Polyxeni Potter, Atlanta, Georgia, USA David Brandling-Bennet, Washington, D.C., USA Associate Editors Donald S. Burke, Baltimore, Maryland, USA Charles Ben Beard, Ft. Collins, Colorado, USA Jay C. Butler, Anchorage, Alaska David Bell, Atlanta, Georgia, USA Charles H. Calisher, Ft. Collins, Colorado, USA Arturo Casadevall, New York, New York, USA Patrice Courvalin, Paris, France Kenneth C. Castro, Atlanta, Georgia, USA Stephanie James, Bethesda, Maryland, USA Thomas Cleary, Houston, Texas, USA Brian W.J. Mahy, Atlanta, Georgia, USA Anne DeGroot, Providence, Rhode Island, USA Takeshi Kurata, Tokyo, Japan Vincent Deubel, Shanghai, China Martin I. Meltzer, Atlanta, Georgia, USA Ed Eitzen, Washington, D.C., USA Duane J. Gubler, Honolulu, Hawaii, USA David Morens, Bethesda, Maryland, USA Scott Halstead, Arlington, Virginia, USA J. Glenn Morris, Baltimore, Maryland, USA David L. Heymann, Geneva, Switzerland Tanja Popovic, Atlanta, Georgia, USA Sakae Inouye, Tokyo, Japan Patricia M. Quinlisk, Des Moines, Iowa, USA Charles King, Cleveland, Ohio, USA Keith Klugman, Atlanta, Georgia, USA Gabriel Rabinovich, Buenos Aires, Argentina S.K. Lam, Kuala Lumpur, Malaysia Didier Raoult, Marseilles, France Bruce R. Levin, Atlanta, Georgia, USA Pierre Rollin, Atlanta, Georgia, USA Myron Levine, Baltimore, Maryland, USA David Walker, Galveston, Texas, USA Stuart Levy, Boston, Massachusetts, USA John S. MacKenzie, Brisbane, Australia Henrik C. Wegener, Copenhagen, Denmark Tom Marrie, Edmonton, Alberta, Canada Copy Editors John E. McGowan, Jr., Atlanta, Georgia, USA Angie Frey, Ronnie Henry, Anne Mather, Carol Snarey, Stephen S. Morse, New York, New York, USA Cathy Young Philip P. Mortimer, London, United Kingdom Production Fred A. Murphy, Davis, California, USA Barbara E. Murray, Houston, Texas, USA Reginald Tucker, Ann Jordan, Maureen Marshall P. Keith Murray, Ames, Iowa, USA Editorial Assistant Stephen Ostroff, Atlanta, Georgia, USA Carolyn Collins Rosanna W. Peeling, Geneva, Switzerland David H. Persing, Seattle, Washington, USA Gianfranco Pezzino, Topeka, Kansas, USA www.cdc.gov/eid Richard Platt, Boston, Massachusetts, USA Mario Raviglione, Geneva, Switzerland Emerging Infectious Diseases Leslie Real, Atlanta, Georgia, USA Emerging Infectious Diseases is published monthly by the David Relman, Palo Alto, California, USA National Center for Infectious Diseases, Centers for Disease Nancy Rosenstein, Atlanta, Georgia, USA Control and Prevention, 1600 Clifton Road, Mailstop D61, Atlanta, GA 30333, USA. Telephone 404-371-5329, Connie Schmaljohn, Frederick, Maryland, USA fax 404-371-5449, email [email protected]. Tom Schwan, Hamilton, Montana, USA Ira Schwartz, Valhalla, New York, USA The opinions expressed by authors contributing to this journal Tom Shinnick, Atlanta, Georgia, USA do not necessarily reflect the opinions of the Centers for Disease Patricia Simone, Atlanta, Georgia, USA Control and Prevention or the institutions with which the authors Bonnie Smoak, Bethesda, Maryland, USA are affiliated. Rosemary Soave, New York, New York, USA P. Frederick Sparling, Chapel Hill, North Carolina, USA All material published in Emerging Infectious Diseases is in Jan Svoboda, Prague, Czech Republic the public domain and may be used and reprinted without special Bala Swaminathan, Atlanta, Georgia, USA permission; proper citation, however, is required. Robert Swanepoel, Johannesburg, South Africa Use of trade names is for identification only and does not Phillip Tarr, Seattle, Washington, USA imply endorsement by the Public Health Service or by the U.S. Timothy Tucker, Cape Town, South Africa Department of Health and Human Services. Elaine Tuomanen, Memphis, Tennessee, USA Mary E. Wilson, Cambridge, Massachusetts, USA ∞ Emerging Infectious Diseases is printed on acid-free paper that meets John Ward, Atlanta, Georgia, USA the requirements of ANSI/NISO 239.48-1992 (Permanence of Paper) Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 3, March 2005 A Peer-Reviewed Journal Tracking and Analyzing Disease Trends Vol. 11, No. 3, March 2005 Ebola Virus Antibodies in Dogs and Human Risk . .385 L. Allela et al. This first report suggests that dogs can be asympto- matically infected with Ebola virus. Probable Psittacosis Outbreak Linked to Wild Birds . .391 B.L. Telfer et al. Residence in the upper Blue Mountains, age 50–64 years, contact with wild birds, and lawn mowing without a grass catcher were associated On the Cover with psittacosis. George Seurat (1859–1891) Sunday Afternoon on the Island Reptile-associated of La Grande Jatte (1884–86) Salmonellosis . .398 Oil on canvas (2.08 m × 3.08 m) B. de Jong et al. The Art Institute of Chicago, Helen Birch Bartlett Memorial Collection Import restrictions and public awareness campaigns are effective against this common About the Cover p. 512 childhood infection. SARS Risk Perceptions in Perspective Healthcare Workers, Japan . .404 Fly Transmission T. Imai et al. p. 362 of Campylobacter . .361 Perceptions of risk for SARS and countermeasures G.L. Nichols et al. among healthcare professionals indicate that imple- Fly transmission may be involved in the annual menting countermeasures should be a high priority. Campylobacter epidemic. Neutralizing Antibody Response to SARS Coronavirus . .411 Research N.J. Temperton et al. Disease Risk from Foods, SARS-CoV spike protein pseudotypes are the basis England and Wales . .365 of an in vitro microneutralization assay sensitive and specific for SARS-CoV neutralizing antibodies. G.K. Adak et al. Disease impact and risks were estimated by food p. 386 type. SARS-related Perceptions in Hong Kong . .417 Rapid Identification of J.T.F. Lau et al. Emerging Pathogens . .373 The public in Hong Kong may not be psychological- ly prepared for SARS resurgence. R. Sampath et al. New surveillance approach can analyze >900 poly- merase chain reactions per day. Risk Assessment of West Nile Virus Vectors . .425 Drug Prescribing for Pneumonia A.M. Kilpatrick et al. in Ambulatory Care . .380 Culex pipiens and Cx. restuans are important in transmitting virus from birds to humans. C. MacDougall et al. Higher levels of fluoroquinolone use were associat- ed with increasing patient age and later study year. Methicillin-resistant Staphylococcus aureus in Horses and Horse Personnel . .430 A Peer-Reviewed Journal Tracking and Analyzing Disease Trends Vol. 11, No. 3, March 2005 J.S. Weese et al. Methicillin-resistant Staphylococcus aureus was isolated from horses and horse personnel in a 476 Babesia microti, Upstate pattern suggestive of interspecies transmission New York of a human-origin clone. S.J. Kogut et al. Malaria Risk in Travelers . .436 479 Pythiosis in Africa H.H. Askling et al. C. Rivierre et al. Malaria risk around the world was assessed by 482 Hepatitis E Infections, Victoria, using Swedish surveillance data from 1997 to 2003 Australia with an extensive travel database as denominator. B.C. Cowie et al. Policy Review 485 Concomitant Tickborne Infections Notifiable Disease Surveillance p. 447 S. Lotric-Furlan et al. and Practicing Physicians . .442 G. Krause et al. 489 Noroviruses in Archival Surveillance data should be delivered to physicians Samples through occasional nonelectronic reports on current S. Skraber et al. issues of local public health importance. Another Dimension Dispatches 492 Rats, Lice, and Zinsser 446 SARS-CoV Transmitted from G. Weissmann Human to Pig W. Chen et al. Commentary 449 Mimivirus in Pneumonia Patients 497 Emerging Infectious Diseases: B. La Scola et al. 10 Years Running J.E. McDade et al. 453 Methicillin-resistant Staphylococcus aureus G. Regev-Yochay et al. Letters 457 Inquilinus limosus in Cystic p. 468 499 Malaria and Travel to the Fibrosis Patients Dominican Republic N. Wellinghausen et al. 500 Buruli Ulcer in Benin 460 Fever Screening at Airports 501 Mycobacterium tuberculosis Drug and Imported Dengue Resistance P.Y. Shu et al. 503 Endogeneity in Logistic 463 Rumor Surveillance and Avian Regression Models (Replies) Influenza H5N1 G. Samaan et al. 505 Rectal Lymphogranuloma Venereum, France 467 Human Metapneumovirus RNA 506 Pertussis in Soldiers, Israel in Encephalitis Patient O. Schildgen et al. 508 Food Safety for First Responders 471 Japanese Encephalitis Virus in 509 Rickettsiae in Ixodid Ticks, Sicily Meningitis Patients M. Kuwayama et al. News & Notes 474 Identifying Relapsing Fever About the Cover Borrelia, Senegal 512 Optics and Biologic Correctness H. Brahim et al. P. Potter 514 List of Reviewers Fly Transmission of Campylobacter Gordon L. Nichols* An annual increase in Campylobacter infection in single main driver for human Campylobacter infection. The England and Wales begins in May and reaches a maximum possible seasonal drivers were examined, and only vector in early June. This increase occurs in all age groups and is transmission by flies appears to provide a convincing seen in all geographic areas. Examination of risk factors explanation for the observed seasonal trends (Table). that might explain this seasonal increase identifies flies as The seasonal increase in Campylobacter infections in a potential source
Load more

Recommended publications
  • Determination of the Effects That a Previously Uncharacterized Secreted Product from Klebsiella Pneumoniae Has on Citrobacter Fr
    East Tennessee State University Digital Commons @ East Tennessee State University Undergraduate Honors Theses Student Works 5-2017 Determination of the effects that a previously uncharacterized secreted product from Klebsiella pneumoniae has on Citrobacter freundii and Enterobacter cloacae biofilms Cody M. Hastings Follow this and additional works at: https://dc.etsu.edu/honors Part of the Bacteria Commons, Bacteriology Commons, Biological Phenomena, Cell Phenomena, and Immunity Commons, Cell and Developmental Biology Commons, Medical Cell Biology Commons, Medical Microbiology Commons, Microbial Physiology Commons, and the Pathogenic Microbiology Commons Recommended Citation Hastings, Cody M., "Determination of the effects that a previously uncharacterized secreted product from Klebsiella pneumoniae has on Citrobacter freundii and Enterobacter cloacae biofilms" (2017). Undergraduate Honors Theses. Paper 419. https://dc.etsu.edu/ honors/419 This Honors Thesis - Withheld is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State University. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of Digital Commons @ East Tennessee State University. For more information, please contact [email protected]. Determination of the effects that a previously uncharacterized secreted product from Klebsiella pneumoniae has on Citrobacter freundii and Enterobacter cloacae biofilms By Cody Hastings An Undergraduate Thesis Submitted in Partial Fulfillment of the Requirements
    [Show full text]
  • Upper and Lower Case Letters to Be Used
    Isolation, characterization and genome sequencing of a soil-borne Citrobacter freundii strain capable of detoxifying trichothecene mycotoxins by Rafiqul Islam A Thesis Presented to The University of Guelph In Partial Fulfilment of Requirements for the Degree of Doctor of Philosophy in Plant Agriculture Guelph, Ontario, Canada © Rafiqul Islam, April, 2012 ABSTRACT ISOLATION, CHARACTERIZATION AND GENOME SEQUENCING OF A SOIL- BORNE CITROBACTER FREUNDII STRAIN CAPABLE OF DETOXIFIYING TRICHOTHECENE MYCOTOXINS Rafiqul Islam Advisors: University of Guelph, 2012 Dr. K. Peter Pauls Dr. Ting Zhou Cereals are frequently contaminated with tricthothecene mycotoxins, like deoxynivalenol (DON, vomitoxin), which are toxic to humans, animals and plants. The goals of the research were to discover and characterize microbes capable of detoxifying DON under aerobic conditions and moderate temperatures. To identify microbes capable of detoxifying DON, five soil samples collected from Southern Ontario crop fields were tested for the ability to convert DON to a de-epoxidized derivative. One soil sample showed DON de-epoxidation activity under aerobic conditions at 22-24°C. To isolate the microbes responsible for DON detoxification (de-epoxidation) activity, the mixed culture was grown with antibiotics at 50ºC for 1.5 h and high concentrations of DON. The treatments resulted in the isolation of a pure DON de-epoxidating bacterial strain, ADS47, and phenotypic and molecular analyses identified the bacterium as Citrobacter freundii. The bacterium was also able to de-epoxidize and/or de-acetylate 10 other food-contaminating trichothecene mycotoxins. A fosmid genomic DNA library of strain ADS47 was prepared in E. coli and screened for DON detoxification activity. However, no library clone was found with DON detoxification activity.
    [Show full text]
  • Ohio Department of Health, Bureau of Infectious Diseases Disease Name Class A, Requires Immediate Phone Call to Local Health
    Ohio Department of Health, Bureau of Infectious Diseases Reporting specifics for select diseases reportable by ELR Class A, requires immediate phone Susceptibilities specimen type Reportable test name (can change if Disease Name other specifics+ call to local health required* specifics~ state/federal case definition or department reporting requirements change) Culture independent diagnostic tests' (CIDT), like BioFire panel or BD MAX, E. histolytica Stain specimen = stool, bile results should be sent as E. histolytica DNA fluid, duodenal fluid, 260373001^DETECTED^SCT with E. histolytica Antigen Amebiasis (Entamoeba histolytica) No No tissue large intestine, disease/organism-specific DNA LOINC E. histolytica Antibody tissue small intestine codes OR a generic CIDT-LOINC code E. histolytica IgM with organism-specific DNA SNOMED E. histolytica IgG codes E. histolytica Total Antibody Ova and Parasite Anthrax Antibody Anthrax Antigen Anthrax EITB Acute Anthrax EITB Convalescent Anthrax Yes No Culture ELISA PCR Stain/microscopy Stain/spore ID Eastern Equine Encephalitis virus Antibody Eastern Equine Encephalitis virus IgG Antibody Eastern Equine Encephalitis virus IgM Arboviral neuroinvasive and non- Eastern Equine Encephalitis virus RNA neuroinvasive disease: Eastern equine California serogroup virus Antibody encephalitis virus disease; LaCrosse Equivocal results are accepted for all California serogroup virus IgG Antibody virus disease (other California arborviral diseases; California serogroup virus IgM Antibody specimen = blood, serum, serogroup
    [Show full text]
  • René Dubos, Tuberculosis, and the “Ecological Facets of Virulence”
    HPLS (2017) 39:15 DOI 10.1007/s40656-017-0142-5 ORIGINAL PAPER René Dubos, tuberculosis, and the “ecological facets of virulence” Mark Honigsbaum1 Received: 15 January 2017 / Accepted: 23 June 2017 / Published online: 4 July 2017 © The Author(s) 2017. This article is an open access publication Abstract Reflecting on his scientific career toward the end of his life, the French- educated medical researcher Rene´ Dubos presented his flowering as an ecological thinker as a story of linear progression—the inevitable product of the intellectual seeds planted in his youth. But how much store should we set by Dubos’s account of his ecological journey? Resisting retrospective biographical readings, this paper seeks to relate the development of Dubos’s ecological ideas to his experimental practices and his career as a laboratory researcher. In particular, I focus on Dubos’s studies of tuberculosis at the Rockefeller Institute in the period 1944–1956—studies which began with an inquiry into the tubercle bacillus and the physiochemical determinants of virulence, but which soon encompassed a wider investigation of the influence of environmental forces and host–parasite interactions on susceptibility and resistance to infection in animal models. At the same time, through a close reading of Dubos’s scientific papers and correspondence, I show how he both drew on and distinguished his ecological ideas from those of other medical researchers such as Theobald Smith, Frank Macfarlane Burnet, and Frank Fenner. However, whereas Burnet and Fenner tended to view ecological interactions at the level of populations, Dubos focused on the interface of hosts and parasites in the physio- logical environments of individuals.
    [Show full text]
  • Infectious Disease in Philadelphia, 1690- 1807
    ABSTRACT Title of Dissertation: INFECTIOUS DISEASE IN PHILADELPHIA, 1690- 1807: AN ECOLOGICAL PERSPECTIVE Gilda Marie Anroman, Doctor of Philosophy, 2006 Dissertation directed by: Professor Mary Corbin Sies Department of American Studies This dissertation examines the multiple factors that influenced the pattern and distribution of infectious disease in Philadelphia between the years 1690 and 1807, and explores the possible reasons for the astonishingly high level of death from disease throughout the city at this time . What emerges from this study is a complex picture of a city undergoing rapid cultural and epidemiological changes . Large -scale immigration supplied a susceptible population group, as international trade, densely packed street s, unsanitary living conditions, and a stagnant and contaminated water supply combined to create ideal circumstances for the proliferation of both pathogen s and vectors, set ting the stage for the many public health crises that plagued Philadelphia for more than one hundred years. This study uses an ecological perspective to understand how disease worked in Philadelphia . The idea that disease is virtually always a result of the interplay of the environment, the genetic and physical make -up of the individual , and the agent of disease is one of the most importan t cause and effect ideas underpinned by epidemiology. This dissertation integrates me thods from the health sciences, humanities, and social sciences to demonstrate how disease “emergence” in Philadelphia was a dynamic feature of the interrelationships between people and their socio -cultural and physical environments. Classic epidemiological theory , informed by ecological thinking, is used to rev isit the city’s reconstructed demographic data, bills of mortality, selected diaries (notably that of Elizabeth Drinker ), personal letters, contemporary observations and medical literature .
    [Show full text]
  • Chemical Heritage Foundation Boris Magasanik
    CHEMICAL HERITAGE FOUNDATION BORIS MAGASANIK Transcript of an interview Conducted by Sondra Schlesinger In three sessions between 1993 and 1995 This interview has been designated as Free Access. One may view, quote from, cite, or reproduce the oral history with the permission of CHF. Please note: Users citing this interview for purposes of publication are obliged under the terms of the Chemical Heritage Foundation Oral History Program to credit CHF using the format below: Boris Magasanik, interview by Sondra Schlesinger, 1993-1995 (Philadelphia: Chemical Heritage Foundation, Oral History Transcript # 0186). Chemical Heritage Foundation Oral History Program 315 Chestnut Street Philadelphia, Pennsylvania 19106 The Chemical Heritage Foundation (CHF) serves the community of the chemical and molecular sciences, and the wider public, by treasuring the past, educating the present, and inspiring the future. CHF maintains a world-class collection of materials that document the history and heritage of the chemical and molecular sciences, technologies, and industries; encourages research in CHF collections; and carries out a program of outreach and interpretation in order to advance an understanding of the role of the chemical and molecular sciences, technologies, and industries in shaping society. BORIS MAGASANIK 1919 Born in Kharkoff, Russia, on December 19 Education 1941 B.S., biochemistry, City College of New York 1948 Ph.D., biochemistry, Columbia University Professional Experience Columbia University 1948-1949 Research Assistant, Department
    [Show full text]
  • Use of the Diagnostic Bacteriology Laboratory: a Practical Review for the Clinician
    148 Postgrad Med J 2001;77:148–156 REVIEWS Postgrad Med J: first published as 10.1136/pmj.77.905.148 on 1 March 2001. Downloaded from Use of the diagnostic bacteriology laboratory: a practical review for the clinician W J Steinbach, A K Shetty Lucile Salter Packard Children’s Hospital at EVective utilisation and understanding of the Stanford, Stanford Box 1: Gram stain technique University School of clinical bacteriology laboratory can greatly aid Medicine, 725 Welch in the diagnosis of infectious diseases. Al- (1) Air dry specimen and fix with Road, Palo Alto, though described more than a century ago, the methanol or heat. California, USA 94304, Gram stain remains the most frequently used (2) Add crystal violet stain. USA rapid diagnostic test, and in conjunction with W J Steinbach various biochemical tests is the cornerstone of (3) Rinse with water to wash unbound A K Shetty the clinical laboratory. First described by Dan- dye, add mordant (for example, iodine: 12 potassium iodide). Correspondence to: ish pathologist Christian Gram in 1884 and Dr Steinbach later slightly modified, the Gram stain easily (4) After waiting 30–60 seconds, rinse with [email protected] divides bacteria into two groups, Gram positive water. Submitted 27 March 2000 and Gram negative, on the basis of their cell (5) Add decolorising solvent (ethanol or Accepted 5 June 2000 wall and cell membrane permeability to acetone) to remove unbound dye. Growth on artificial medium Obligate intracellular (6) Counterstain with safranin. Chlamydia Legionella Gram positive bacteria stain blue Coxiella Ehrlichia Rickettsia (retained crystal violet).
    [Show full text]
  • The Serology of Citrobacter Koseri, Levinea Malonatica, and Levinea Amalonatica
    THE SEROLOGY OF CITROBACTER KOSERI, LEVINEA MALONATICA, AND LEVINEA AMALONATICA R. J. GROSSAND B. ROWE Salmonella and Shigella Reference Laboratory, Central Public Health Laboratory, Colindale Avenue, London NW9 SHT FREDERIKSEN(1970) described a collection of 30 strains belonging to the genus Citrobacter, but differing in several respects from C.freundii. Adonitol was fermented, malonate was utilised, indole was produced, and there was no growth in Moeller’s potassium cyanide medium (KCN). Hydrogen sulphide (H2S) production in ferric chloride gelatin was weak. Frederiksen considered that these strains should be regarded as a new species, and proposed the name C. koseri. Booth and McDonald (1971) examined 40 biochemically similar strains and proposed that they be regarded as a new species of Citrobacter. Young et al. (1971) studied 108 strains and proposed the establishment of a new genus, Levinea, having two species, L. malonatica and L. amalonatica. The biochemical reactions described for L. malonatica were similar to those of C. koseri, but H2S production was not detected in triple sugar iron agar (TSI agar). The reactions of L. amalonatica differed in that adonitol was not fermented, malonate was not utilised, and growth was always seen in KCN. Limited serological studies showed considerable antigenic sharing within the proposed species L. malonatica. Gross, Rowe and Easton (1973) studied four cases of neonatal meningitis in a premature-baby unit; C. koseri was the causative organism in all, but serological studies showed that two distinct serotypes were involved. We now report a biochemical and serological study of representative strains from all these authors, and a previously undescribed strain.
    [Show full text]
  • Evolutionary Dynamics of the Vapd Gene in Helicobacter Pylori and Its
    ISSN Online: 2372-0956 Symbiosis www.symbiosisonlinepublishing.com Research Article SOJ Microbiology & Infectious Diseases Open Access Evolutionary dynamics of the vapD gene in Helicobacter pylori and its wide distribution among bacterial phyla Gabriela Delgado-Sapién1, Rene Cerritos-Flores2, Alejandro Flores-Alanis1, José L Méndez1, Alejandro Cravioto1, Rosario Morales-Espinosa1* *1Laboratorio de Genómica Bacteriana, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, México 04510. 2Centro de Investigación en Políticas, Población y Salud, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, México 04510. Received: 12th August , 2020; Accepted: 15th November 2020 ; Published: 03rd December, 2020 *Corresponding author: RosarioMorales-Espinosa, PhD, MD, Laboratorio de Genómica Bacteriana, Departamento de Microbiología y Parasi- tología. Universidad Nacional Autónoma de México. Avenida Universidad 3000, Colonia Ciudad Universitaria, Delegación Coyoacán, C.P. 04510, México City, México.Tel.: +525 5523 2135; Fax: +525 5623 2114 E-mail: [email protected] factors [1,2,3]. Genetic diversity is seen among H. pylori strains Abstract from different origins and ethnic populations, as well as within The vapD gene is present in microorganisms from different phyla H. pylori populations within a single stomach. It is well known and encodes for the virulence-associated protein D (VapD). In some that H. pylori is a highly recombinant microorganism [4-8] and microorganisms, it has been suggested that vapD participates in either a natural transformant, which explains its genomic variability protecting the bacteria from respiratory burst within the macrophage and diversity that favour a better adaptive capacity and its or in facilitating the persistence of the microorganism within the permanence on the gastric mucosa for decades.
    [Show full text]
  • Biofilm Formation by Pathogens Causing Ventilator-Associated Pneumonia at Intensive Care Units in a Tertiary Care Hospital: an Armor for Refuge
    Hindawi BioMed Research International Volume 2021, Article ID 8817700, 10 pages https://doi.org/10.1155/2021/8817700 Research Article Biofilm Formation by Pathogens Causing Ventilator-Associated Pneumonia at Intensive Care Units in a Tertiary Care Hospital: An Armor for Refuge Sujata Baidya ,1 Sangita Sharma,1 Shyam Kumar Mishra ,1,2 Hari Prasad Kattel,1 Keshab Parajuli,1 and Jeevan Bahadur Sherchand1 1Department of Clinical Microbiology, Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal 2School of Optometry and Vision Science, University of New South Wales, Australia Correspondence should be addressed to Sujata Baidya; [email protected] Received 11 September 2020; Revised 26 January 2021; Accepted 21 May 2021; Published 29 May 2021 Academic Editor: Stanley Brul Copyright © 2021 Sujata Baidya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Emerging threat of drug resistance among pathogens causing ventilator-associated pneumonia (VAP) has resulted in higher hospital costs, longer hospital stays, and increased hospital mortality. Biofilms in the endotracheal tube of ventilated patients act as protective shield from host immunity. They induce chronic and recurrent infections that defy common antibiotics. This study intended to determine the biofilm produced by pathogens causing VAP and their relation with drug resistance. Methods. Bronchoalveolar lavage and deep tracheal aspirates (n =70) were obtained from the patients mechanically ventilated for more than 48 hours in the intensive care units of Tribhuvan University Teaching Hospital, Kathmandu, and processed according to the protocol of the American Society for Microbiology (ASM).
    [Show full text]
  • CHAPTER V Some of the Charter Members
    YALE JOURNAL OF BIOLOGY AND MEDICINE 46, 32-51 (1972) CHAPTER V Some of the Charter Members The American Epidemiological Society was, at the start, a small, but fervent organization. The founding fathers who controlled it played an earnest and mean- ingful role in the early life of this organization which could not help but contribute to its success. In order to give some idea of the personalities involved, brief biographical sketches of a few of the charter members are given. Those 26 persons to whom Emerson and Godfrey had sent out letters of invita- tion in October 1927 and from whom they had received favorable replies, I believe, represent the true charter members of our Society. Another and longer list which bears the name of "Charter Members of the AES" has been unearthed among Haven Emerson's notes, made in the early years of his secretaryship. This list of 40, includes the names of 14 who were elected at the first meeting of the Society, but I have chosen the original 26 as the official charter members. In the early years there seemed to be no need to enlarge the Society beyond the group of 40 mentioned on Emerson's second list. At least it was an ideal group for the type of spirited discussions which were held at AES meetings for the next 5 years. It may be of interest to see what the backgrounds of some of this early group of 40 had been. Three of the men (Frost, Leake and Maxcy) had spent longer or shorter periods of apprenticeship on what might be called observational and statistical epidemiological field studies which dealt with subjects such as polio- myelitis, influenza, and murine typhus.
    [Show full text]
  • Campylobacter (C
    GI Panel Limitations: Copied from the BioFire GI Panel Package Insert. RFIT-PRT-0143-04 June 2017 Include in all sections: This test is a qualitative test and does not provide a quantitative value for the organism(s) in the sample. The performance of this test has not been established for patients without signs and symptoms of gastrointestinal illness. Virus, bacteria, and parasite nucleic acid may persist in vivo independently of organism viability. Additionally, some organisms may be carried asymptomatically. Detection of organism targets does not imply that the corresponding organisms are infectious or are the causative agents for clinical symptoms. Virus, bacteria, and parasite nucleic acid may persist in vivo independently of organism viability. Additionally, some organisms may be carried asymptomatically. Detection of organism targets does not imply that the corresponding organisms are infectious or are the causative agents for clinical symptoms. A negative FilmArray GI Panel result does not exclude the possibility of gastrointestinal infection. Negative test results may occur from sequence variants in the region targeted by the assay, the presence of inhibitors, technical error, sample mix-up, or an infection caused by an organism not detected by the panel. Test results may also be affected by concurrent antimicrobial therapy or levels of organism in the sample that are below the limit of detection for the test. Negative results should not be used as the sole basis for diagnosis, treatment, or other management decisions. The performance of this test has not been evaluated for immunocompromised individuals. Campylobacter (C. jejuni/C. coli/C. upsaliensis) The FilmArray GI Panel contains two assays (Campy 1 and Campy 2) designed to together detect, but not differentiate, the most common Campylobacter species associated with human gastrointestinal illness: C.
    [Show full text]